A cardiac glycoside used as a treatment for atrial fibrillation.
Transo-Pharm focus on API’s for the generic market; a distinctive offer has been built by this privately owned company over many years. Their unique capability to offer regulatory support, combined with the shared service provided by our Chemical and Regulatory experts, means that our clients are supported within the framework of ever increasing regulation.
Alfa Chemicals offers solutions to the global pharmaceutical market, including contract manufacturing for intermediates & APIs; supply chain consolidation; unique and tailored pharmaceutical APIs; excipients; plus bespoke buffer solutions.
Digoxin slows the heart rate but increases stroke volume, providing an increase in blood pressure which help relieve atrial fibrillation, atrial flutter, and heart failure